Overview

Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca